Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 79

1.

Coronary Sinus Reducer Implantation: Potential New Horizons Where it Should Be Tested.

Lozano I, Capin E, Lee Hwang DH, Lopez-Palop R, Segovia E.

JACC Cardiovasc Interv. 2018 Aug 27;11(16):1658. doi: 10.1016/j.jcin.2018.05.018. No abstract available.

PMID:
30139474
2.

Lesion Complexity and Prolonged Antiplatelet Therapy: The Missing Variable to Complete the Puzzle.

Lozano I, Rondan J, Vegas JM, Segovia E.

J Am Coll Cardiol. 2018 Mar 13;71(10):1186-1187. doi: 10.1016/j.jacc.2017.12.055. No abstract available.

PMID:
29519361
3.

Chronic Kidney Disease and Antiplatelet Therapy: A Worrying Gap Between Evidence Based Medicine and Clinical Practice.

Lozano I, Rondan J, Vegas JM, Segovia E.

JACC Cardiovasc Interv. 2018 Feb 12;11(3):319-320. doi: 10.1016/j.jcin.2017.11.016. No abstract available.

PMID:
29413247
4.

Cost-Effectiveness of Long-Term Ticagrelor in Patients With Prior Myocardial Infarction: Analysis by Subgroups.

Lozano I, Rondan J, Vegas JM, Segovia E.

J Am Coll Cardiol. 2018 Jan 2;71(1):107-108. doi: 10.1016/j.jacc.2017.08.083. No abstract available.

PMID:
29301622
5.

Stent Choice in Very Large Left Main Lesions in 3 Patients.

Lozano I, Rondan J, Vegas JM, Segovia E.

Tex Heart Inst J. 2017 Oct 1;44(5):353-356. doi: 10.14503/THIJ-17-6190. eCollection 2017 Oct.

6.

Cangrelor or Abciximab as First Choice in Cardiogenic Shock.

Lozano I, Rondan J, Vegas JM, Segovia E.

JACC Cardiovasc Interv. 2017 Dec 11;10(23):2467-2468. doi: 10.1016/j.jcin.2017.09.017. No abstract available.

PMID:
29217012
7.

Antithrombotic Therapy After Percutaneous Aortic Valve Implantation: Large Gaps for a Matter of Extreme Importance.

Lozano Í, Rondán J, Vegas JM, Segovia E.

Rev Esp Cardiol (Engl Ed). 2018 Apr;71(4):308. doi: 10.1016/j.rec.2017.08.023. Epub 2017 Dec 6. English, Spanish. No abstract available.

PMID:
29203167
8.

Initiatives to Achieve Excellence in the Care of Acute Coronary Syndrome.

Lozano Í, Rondán J, Vegas JM, Segovia E.

Rev Esp Cardiol (Engl Ed). 2017 Nov;70(11):1026-1027. doi: 10.1016/j.rec.2017.05.035. Epub 2017 Jul 31. English, Spanish. No abstract available.

PMID:
28774631
9.

Duration of Double Antiplatelet Therapy in Patients With Coronary and Peripheral Arterial Disease: The Key Might Be in the Type of Drug.

Lozano I, Rondan J, Vegas JM, Segovia E.

JACC Cardiovasc Interv. 2017 Jul 24;10(14):1467-1468. doi: 10.1016/j.jcin.2017.05.041. No abstract available.

10.

Human Peritoneal Mesothelial Cell Death Induced by High-Glucose Hypertonic Solution Involves Ca2+ and Na+ Ions and Oxidative Stress with the Participation of PKC/NOX2 and PI3K/Akt Pathways.

Simon F, Tapia P, Armisen R, Echeverria C, Gatica S, Vallejos A, Pacheco A, Sanhueza ME, Alvo M, Segovia E, Torres R.

Front Physiol. 2017 Jun 13;8:379. doi: 10.3389/fphys.2017.00379. eCollection 2017.

11.

[Encapsulating peritoneal sclerosis].

Torres R, Ebner P, Sanhueza ME, Alvo M, Segovia E, Segura P.

Rev Med Chil. 2017 Jan;145(1):41-48. doi: 10.4067/S0034-98872017000100006. Spanish.

12.

Future Demand for Interventional Procedures in Structural Heart Disease. Is It Wise to Perform TAVI Only in Centers With On-site Cardiac Surgery?

Lozano Í, Rondán J, Vegas JM, Segovia E.

Rev Esp Cardiol (Engl Ed). 2017 Apr;70(4):307. doi: 10.1016/j.rec.2017.01.014. Epub 2017 Feb 21. English, Spanish. No abstract available.

PMID:
28254254
13.

Percutaneous Revascularization of Left Main Disease: Could the Angiographic Follow-Up Improve the Survival?

Lozano I, Rondan J, Vegas JM, Segovia E.

J Am Coll Cardiol. 2017 Feb 7;69(5):597-598. doi: 10.1016/j.jacc.2016.09.986. No abstract available.

14.

Consensus Document on Polypill and Secondary Prevention. Does It Include Patients With Stents?

Lozano I, Vegas JM, Rondán J, Segovia E.

Rev Esp Cardiol (Engl Ed). 2016 Oct;69(10):995. doi: 10.1016/j.rec.2016.06.002. Epub 2016 Aug 17. English, Spanish. No abstract available.

PMID:
27544237
15.

Outpatient percutaneous coronary intervention: An old technique necessary in the present and future.

Lozano I, Samaniego B, Rondan J, Vegas JM, Hernández E, Segovia E.

Int J Cardiol. 2016 Nov 15;223:224-225. doi: 10.1016/j.ijcard.2016.08.173. Epub 2016 Aug 15. No abstract available.

PMID:
27541660
16.

The dilemma of identification of the culprit lesion in multivessel disease in patients with complex collateral circulation.

Lozano I, Rondan J, Vegas JM, Segovia E.

Int J Cardiol. 2016 Nov 15;223:34-36. doi: 10.1016/j.ijcard.2016.07.289. Epub 2016 Aug 3. No abstract available.

PMID:
27529586
17.

Usefulness of the catheter extension in combination with the fractional flow reserve in coronary grafts.

Lozano I, Rondan J, Vegas JM, Segovia E.

Int J Cardiol. 2016 Nov 1;222:287-288. doi: 10.1016/j.ijcard.2016.07.240. Epub 2016 Jul 30. No abstract available.

PMID:
27497112
18.

Pre-Hospital Ticagrelor in ST-Segment Elevation Myocardial Infarction: Should the Hypothesis Be Re-Evaluated?

Lozano I, Rondan J, Vegas JM, Segovia E.

JACC Cardiovasc Interv. 2016 Jul 11;9(13):1414-5. doi: 10.1016/j.jcin.2016.04.046. No abstract available.

19.

Sustainability of the Health System: Beyond Cost-effectiveness Analyses.

Lozano I, Rondán J, Vegas JM, Segovia E.

Rev Esp Cardiol (Engl Ed). 2016 Sep;69(9):880-1. doi: 10.1016/j.rec.2016.05.002. Epub 2016 Jul 4. English, Spanish. No abstract available.

PMID:
27387051
20.

Usefulness of Rotational Atherectomy in the Current Era.

Lozano I, Rondan J, Vegas JM, Segovia E.

Am J Cardiol. 2016 Jun 1;117(11):1858-9. doi: 10.1016/j.amjcard.2016.02.050. Epub 2016 Mar 10. No abstract available.

PMID:
27040575

Supplemental Content

Loading ...
Support Center